Literature DB >> 24243572

[Diagnosis of and therapy for hepatocellular carcinoma].

T F Greten, N P Malek, S Schmidt, J Arends, P Bartenstein, W Bechstein, T Bernatik, M Bitzer, A Chavan, M Dollinger, D Domagk, O Drognitz, M Düx, S Farkas, G Folprecht, P Galle, M Geißler, G Gerken, D Habermehl, T Helmberger, K Herfarth, R T Hoffmann, M Holtmann, P Huppert, T Jakobs, M Keller, J Klempnauer, F Kolligs, J Körber, H Lang, F Lehner, F Lordick, A Lubienski, M P Manns, A Mahnken, M Möhler, C Mönch, P Neuhaus, C Niederau, M Ocker, G Otto, P Pereira, G Pott, J Riemer, K Ringe, U Ritterbusch, E Rummeny, P Schirmacher, H J Schlitt, K Schlottmann, V Schmitz, A Schuler, H Schulze-Bergkamen, D von Schweinitz, D Seehofer, H Sitter, C P Straßburg, C Stroszczynski, D Strobel, A Tannapfel, J Trojan, I van Thiel, A Vogel, F Wacker, H Wedemeyer, H Wege, A Weinmann, C Wittekind, B Wörmann, C J Zech.   

Abstract

The interdisciplinary guidelines at the S3 level on the diagnosis of and therapy for hepatocellular carcinoma (HCC) constitute an evidence- and consensus-based instrument that is aimed at improving the diagnosis of and therapy for HCC since these are very challenging tasks. The purpose of the guidelines is to offer the patient (with suspected or confirmed HCC) adequate, scientifically based and up-to-date procedures in diagnosis, therapy and rehabilitation. This holds not only for locally limited or focally advanced disease but also for the existence of recurrences or distant metastases. Besides making a contribution to an appropriate health-care service, the guidelines should also provide the foundation for an individually adapted, high-quality therapy. The explanatory background texts should also enable non-specialist but responsible colleagues to give sound advice to their patients concerning specialist procedures, side effects and results. In the medium and long-term this should reduce the morbidity and mortality of patients with HCC and improve their quality of life. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 24243572      PMCID: PMC6318804          DOI: 10.1055/s-0033-1355841

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  558 in total

Review 1.  Hereditary haemochromatosis: diagnosis and management in the gene era.

Authors:  J K Olynyk
Journal:  Liver       Date:  1999-04

2.  Can 40 seconds of compassion reduce patient anxiety?

Authors:  L A Fogarty; B A Curbow; J R Wingard; K McDonnell; M R Somerfield
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

3.  Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.

Authors:  H J Schlitt; M Neipp; A Weimann; K J Oldhafer; E Schmoll; K Boeker; B Nashan; S Kubicka; H Maschek; G Tusch; R Raab; B Ringe; M P Manns; R Pichlmayr
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

4.  The unmet supportive care needs of patients with cancer. Supportive Care Review Group.

Authors:  R Sanson-Fisher; A Girgis; A Boyes; B Bonevski; L Burton; P Cook
Journal:  Cancer       Date:  2000-01-01       Impact factor: 6.860

5.  Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection.

Authors:  T Livraghi; S N Goldberg; S Lazzaroni; F Meloni; L Solbiati; G S Gazelle
Journal:  Radiology       Date:  1999-03       Impact factor: 11.105

6.  An analysis of 412 cases of hepatocellular carcinoma at a Western center.

Authors:  Y Fong; R L Sun; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

7.  Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

Authors:  H Yoshida; Y Shiratori; M Moriyama; Y Arakawa; T Ide; M Sata; O Inoue; M Yano; M Tanaka; S Fujiyama; S Nishiguchi; T Kuroki; F Imazeki; O Yokosuka; S Kinoyama; G Yamada; M Omata
Journal:  Ann Intern Med       Date:  1999-08-03       Impact factor: 25.391

8.  The impact of nutritional status on the prognoses of patients with advanced head and neck cancer.

Authors:  P A van Leeuwen; D J Kuik; W M Klop; H P Sauerwein; G B Snow; J J Quak
Journal:  Cancer       Date:  1999-08-01       Impact factor: 6.860

9.  Resection of hepatocellular carcinoma in cirrhotic patients: longterm results of a prospective study.

Authors:  C Gouillat; D Manganas; G Saguier; R Duque-Campos; P Berard
Journal:  J Am Coll Surg       Date:  1999-09       Impact factor: 6.113

10.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

View more
  31 in total

1.  [Follow-up care for gastrointestinal tumors].

Authors:  M Ebert
Journal:  Internist (Berl)       Date:  2018-05       Impact factor: 0.743

Review 2.  [Living liver donor: indications and technical aspects].

Authors:  S Nadalin; I Capobianco; I Königsrainer; B Harder; A Königsrainer
Journal:  Chirurg       Date:  2015-06       Impact factor: 0.955

Review 3.  [Sonographic diagnostics of liver tumors].

Authors:  C Höner Zu Siederdissen; A Potthoff
Journal:  Internist (Berl)       Date:  2020-02       Impact factor: 0.743

Review 4.  Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives.

Authors:  Markus Rentsch; Tobias Schiergens; Andrej Khandoga; Jens Werner
Journal:  Visc Med       Date:  2016-06-13

5.  [Incidental findings in abdominal ultrasound. Characteristics and clinical interpretation].

Authors:  C Görg; S Kunsch; A Neesse
Journal:  Internist (Berl)       Date:  2014-09       Impact factor: 0.743

Review 6.  Surveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver Cirrhosis.

Authors:  Jens U Marquardt; Marc Nguyen-Tat; Peter R Galle; Marcus A Wörns
Journal:  Visc Med       Date:  2016-04-08

Review 7.  [Surgical treatment of hepatic tumors-liver resection and transplantation].

Authors:  H Lang; S Heinrich; F Bartsch; F Hüttl; J Baumgart; J Mittler
Journal:  Internist (Berl)       Date:  2020-02       Impact factor: 0.743

8.  Liver Transplantation and Liver Resection for Cirrhotic Patients with Hepatocellular Carcinoma: Comparison of Long-Term Survivals.

Authors:  Felix Krenzien; Moritz Schmelzle; Benjamin Struecker; Nathanael Raschzok; Christian Benzing; Maximilian Jara; Marcus Bahra; Robert Öllinger; Igor M Sauer; Andreas Pascher; Johann Pratschke; Andreas Andreou
Journal:  J Gastrointest Surg       Date:  2018-01-23       Impact factor: 3.452

9.  Transient elastography improves detection of liver cirrhosis compared to routine screening tests.

Authors:  Thomas Göbel; Janine Schadewaldt-Tümmers; Lucas Greiner; Christopher Poremba; Dieter Häussinger; Andreas Erhardt
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

Review 10.  [Locoregional and local ablative treatment options for liver tumors].

Authors:  J B Hinrichs; F K Wacker
Journal:  Internist (Berl)       Date:  2020-02       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.